Good Signal Weekly Pulse — Edition 6 (November 2, 2025)

Published · Researched 2026-09-22

Week of October 27, 2025

The week in one paragraph

The story of the week is a principal, a homeless teenager, and a career given away on purpose. In 2024, 16-year-old Landerius "DeDe" Hayes — sleeping in his car and couch-surfing in Ohio — was told to withdraw from Lakota East High School because his mother's move left him without an in-district address. Principal Robert Burnside disagreed, kept Hayes in class and eating in the cafeteria, was placed on administrative leave in November 2024, and chose resignation over termination. Burnside and his wife Angel then took Hayes into their home and became his legal guardians in February 2025. In May 2026, Hayes — now 18 — graduated from Kings High School with Burnside watching; he calls his former principal "Pops" and is training as an aviation mechanic. Burnside told CBS News he has no regrets. Still watching: outlets conflict on Burnside's tenure ("nearly 20 years" vs "31 years" vs founding-teacher-in-1997 math), so "decades-long" is the honest phrasing, and some local reporting reached this dossier only via quoting outlets.

Rising

Schizophrenia treatment finally got a second act. Cobenfy (xanomeline-trospium), approved September 26, 2024, is the first schizophrenia medicine targeting muscarinic receptors instead of dopamine — the first genuinely new mechanism approved in decades. Phase 3 EMERGENT trials showed significant symptom reductions versus placebo, without the weight gain and movement disorders that haunt dopamine blockers. The approval circulated on Threads via individual sharers and outlet accounts. Still watching: the social layer was thin at research time.

Prevention you only think about twice a year. In June 2025 the FDA approved Gilead's Yeztugo (lenacapavir), the first twice-yearly injectable HIV PrEP in the U.S. PURPOSE 1: zero infections among 2,134 participants; PURPOSE 2: two among 2,179 — it beat daily oral Truvada in both trials. The CDC now strongly recommends it, and providers were preparing to offer it free in some settings by March 2026. Still watching: the reported WHO recommendation and Science's Breakthrough of the Year designation weren't verified against primary sources.

Rewilding's quiet workhorses. Two bearded vultures, Alosa and Zierli, were released in Bavaria's Klausbach Valley on June 24, 2026 — the 12th release since 2021 for a bird extinct in the Alps for roughly a century. And in May 2026, forest officials counted roughly 100 gharial hatchlings from four nests at Palighat in the National Chambal Sanctuary — core habitat of a crocodilian once below 250 mature wild individuals. Still watching: the separate Cévennes release wasn't verified; Rajasthan's direct Forest Department announcement wasn't captured, and hatchling survival rates are unpublished.

Falling

Seventy years of one-mechanism psychiatry. Every schizophrenia drug since the 1950s worked through dopamine blockade. Cobenfy just made that a choice rather than a sentence.

The argument of the week

The Burnside story split the internet's conscience. On one side, millions shared it as moral courage in education — recirculated by Black News, Face2Face Africa, the Steve Harvey Morning Show. On the other, Burnside himself told outlets the social-media backlash included accusations of theft and worse. The read here: the cynical version has no evidence beyond suspicion, while the generous version has a paper trail — November 2024 administrative leave, a resignation, February 2025 legal guardianship, a May 2026 diploma — documented across multiple outlets. Sacrifice that verifiable doesn't need your faith. It just needs your attention.

Quiet signals

Gharial survival watch: a hundred hatchlings in May is the right start, but for a Critically Endangered species the number that reaches adulthood is the number that matters — and it isn't published yet. Early, uncertain.
The vultures' first weeks: conservation communities tracked Alosa and Zierli's early days post-release. Two young birds learning a valley — worth watching, too soon to call.

Scoreboard

N/A — editions written out of sequence; no prior calls to grade.

One line to close

One man traded a career for a kid, medicine traded a daily pill for a twice-yearly shot, and a century-extinct vulture got its twelfth second chance.